Literature DB >> 5558593

Classification and staging of malignant tumours in the female pelvis.

.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5558593     DOI： 10.3109/00016347109157278

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  34 in total

1.  Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?

Authors:  Mario M Leitao
Journal:  Oncologist       Date:  2011-01-27

2.  Clinical and prognostic value of the presence of irregular giant nuclear cells in pT1 ovarian clear cell carcinoma.

Authors:  Naoki Matsumoto; Takashi Umezawa; Toru Sasaki; Kuninobu Nakajima; Yukiko Kanetsuna; Hiroshi Sasaki
Journal:  Pathol Oncol Res       Date:  2011-01-28       Impact factor: 3.201

3.  Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.

Authors:  Yu-Li Chen; Ming-Cheng Chang; Chia-Yen Huang; Ying-Cheng Chiang; Han-Wei Lin; Chi-An Chen; Chang-Yao Hsieh; Wen-Fang Cheng
Journal:  Mol Oncol       Date:  2011-12-20       Impact factor: 6.603

Review 4.  Ovarian clear cell adenocarcinoma: a continuing enigma.

Authors:  David S P Tan; Stan Kaye
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

5.  Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).

Authors:  Stefan Kommoss; Dietmar Schmidt; Friedrich Kommoss; Juergen Hedderich; Philipp Harter; Jacobus Pfisterer; Andreas du Bois
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

Review 6.  Primary non-Hodgkin's lymphoma of the vagina. Case report and review of the literature.

Authors:  H G Höffkes; A Schumann; M Uppenkamp; C Teschendorf; A E Schindler; R Parwaresch; G Brittinger
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

7.  Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.

Authors:  Kosuke Yoshihara; Atsushi Tajima; Tetsuro Yahata; Shoji Kodama; Hiroyuki Fujiwara; Mitsuaki Suzuki; Yoshitaka Onishi; Masayuki Hatae; Kazunobu Sueyoshi; Hisaya Fujiwara; Yoshiki Kudo; Kohei Kotera; Hideaki Masuzaki; Hironori Tashiro; Hidetaka Katabuchi; Ituro Inoue; Kenichi Tanaka
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

8.  Pregnancies following conservative treatment of malignant ovarian tumors.

Authors:  K Shiromizu; T Kawana; M Sugase; K Takizawa; K Kawagoe; R Izumi; M Mizuno
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

9.  Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.

Authors:  Rayna K Matsuno; Mark E Sherman; Kala Visvanathan; Marc T Goodman; Brenda Y Hernandez; Charles F Lynch; Olga B Ioffe; David Horio; Charles Platz; Sean F Altekruse; Ruth M Pfeiffer; William F Anderson
Journal:  Cancer Causes Control       Date:  2013-02-03       Impact factor: 2.506

10.  Production of nitric oxide and expression of inducible nitric oxide synthase in ovarian cystic tumors.

Authors:  Rosekeila Simões Nomelini; Lívia Carolina de Abreu Ribeiro; Beatriz Martins Tavares-Murta; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Mediators Inflamm       Date:  2009-01-05       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.